A Study About the Long-Term Safety of TAK-881 in People With Primary Immunodeficiency Diseases

TAK-881OngoingActive not recruitingPhase 3Open NCT06076642 on ClinicalTrials.gov ↗

Population

Loading…

Intervention

Loading…

Comparator

Loading…

Loading…

NCT06076642 · Trial Tracker · ComplyRx